Viewing data from:

CLONAZEPAM

ANDA

CLONAZEPAM | A074925 | CHARTWELL RX SCIENCES LLC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: KLONOPIN(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.0378

per ea

Lowest NADAC/Unit

$0.0199

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
62135077190CLONAZEPAM 2 MG TABLET	$0.0378	EA	Generic	—	2026-06-17
62135077090CLONAZEPAM 1 MG TABLET	$0.0250	EA	Generic	—	2026-06-17
62135076990CLONAZEPAM 0.5 MG TABLET	$0.0199	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs4 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

FIS FABBRICA ITALIANA SINTETICI SPACLONAZEPAM

DMF 75051988

CAMBREX PROFARMACO MILANO SRLCLONAZEPAM

DMF 113511995

PH HEALTH LTDCLONAZEPAM

DMF 162452002

SUN PHARMACEUTICAL INDUSTRIES LTDCLONAZEPAM USP

DMF 177272004

APOTEX PHARMACHEM INDIA PVT LTDCLONAZEPAM USP

DMF 221672008

CENTAUR PHARMACEUTICALS PVT LTDCLONAZEPAM USP

DMF 225802009

R L FINE CHEM PVT LTDCLONAZEPAM

DMF 380702023

DIOSYNTH BVInactiveCLONAZEPAM

DMF 86781990

HOECHST CELANESE CORPInactiveCLONAZEPAM

DMF 118971996

ZHEJIANG HISUN PHARMACEUTICAL CO LTDInactiveCLONAZEPAM, USP

DMF 129861998

LAKE CHEMICALS PRIVATE LTDInactiveCLONAZEPAM

DMF 225832009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 0.5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Sep 30, 1997

No patent or exclusivity listings for this strength.

#002 — 1MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Sep 30, 1997

#003 — 2MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Sep 30, 1997